Cited 0 times in
SAT0186: Treatment response of intravenous tocilizumab in patients with rheumatoid arthritis based on the level of prior exposure to biologic therapy: results from the kobio
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shin, K | - |
dc.contributor.author | Lee, SK | - |
dc.contributor.author | Oh, S | - |
dc.contributor.author | Kim, HA | - |
dc.contributor.author | Song, YW | - |
dc.date.accessioned | 2019-12-10T06:53:37Z | - |
dc.date.available | 2019-12-10T06:53:37Z | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 0003-4967 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/17772 | - |
dc.language.iso | en | - |
dc.title | SAT0186: Treatment response of intravenous tocilizumab in patients with rheumatoid arthritis based on the level of prior exposure to biologic therapy: results from the kobio | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 김, 현아 | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1136/annrheumdis-2018-eular.6111 | - |
dc.citation.title | Annals of the rheumatic diseases | - |
dc.citation.volume | 77 | - |
dc.citation.number | S2 | - |
dc.citation.date | 2018 | - |
dc.citation.startPage | 954 | - |
dc.citation.endPage | 954 | - |
dc.identifier.bibliographicCitation | Annals of the rheumatic diseases, 77(S2). : 954-954, 2018 | - |
dc.embargo.liftdate | 9999-12-31 | - |
dc.embargo.terms | 9999-12-31 | - |
dc.identifier.eissn | 1468-2060 | - |
dc.relation.journalid | J000034967 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.